COLOMBO - An intruding monkey at a Sri Lankan electrical grid sub-station caused a general island-wide blackout on Feb 9, government officials said. The power outage, which began around 11.30am ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.
COLOMBO: An intruding monkey at a Sri Lankan electrical grid sub-station caused a general islandwide blackout on Sunday (Feb 9), government officials said. The power outage began around 11.30am ...
Goldberg said the company "melded" a 'CBS News Sunday Mornings' appearance from her to sell “bad weight loss drugs." By Zoe G. Phillips Whoopi Goldberg has alerted fans of a fake weight loss ad ...
Drugs like Ozempic, Wegovy ... Many patients who need these medications to manage obesity-related health risks still find themselves navigating an insurance maze filled with denials, prior ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter despite missing the company’s initial sales expectations. Zepbound sales reached $1.9 billion in ...
Lilly said on a call with analysts that it still believed there was huge demand for its weight-loss drug Zepbound and diabetes treatment Mounjaro from hundreds of millions of patients. The ...
The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about risks. By Dani Blum The first thing the ad shows is a scale. Over the ...
The ad promotes affordable alternatives to expensive weight loss drugs, claiming the system prioritizes profits over patient health. Concerns have been raised by the Partnership for Safe Medicines ...
For an article about how weight-loss drugs affect marriage and intimacy, one health reporter worked with couples to “hold up a mirror to readers.” By Lisa Miller Times Insider explains who we ...
Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...
Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs FDA says shortage of GLP-1 drug tirzepatide is over GLP-1 meds might reduce blood clot risk in diabetes patients Members ...